News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
255,104 Results
Type
Article (14091)
Company Profile (23)
Press Release (240984)
Multimedia
Podcasts (25)
Webinars (3)
Section
Business (71727)
Career Advice (1125)
Deals (14544)
Drug Delivery (55)
Drug Development (34742)
Employer Resources (47)
FDA (6689)
Job Trends (5838)
News (126025)
Policy (10371)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (789)
Accelerated approval (23)
Adcomms (7)
Allergies (95)
Alliances (11304)
ALS (116)
Alzheimer's disease (743)
Antibody-drug conjugate (ADC) (279)
Approvals (7120)
Artificial intelligence (339)
Autoimmune disease (158)
Automation (25)
Bankruptcy (111)
Best Places to Work (4938)
BIOSECURE Act (4)
Biosimilars (145)
Biotechnology (22)
Bladder cancer (153)
Brain cancer (42)
Breast cancer (491)
Cancer (3617)
Cardiovascular disease (290)
Career advice (903)
Career pathing (13)
CAR-T (159)
CDC (13)
Celiac Disease (1)
Cell therapy (451)
Cervical cancer (31)
Clinical research (32844)
Collaboration (1097)
Company closure (1)
Compensation (601)
Complete response letters (25)
COVID-19 (1064)
CRISPR (53)
C-suite (430)
Cystic fibrosis (68)
Data (5095)
Decentralized trials (1)
Depression (102)
Dermatology (55)
Diabetes (327)
Diagnostics (2596)
Digital health (21)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (168)
Drug pricing (77)
Drug shortages (13)
Duchenne muscular dystrophy (171)
Earnings (54585)
Editorial (23)
Employer branding (10)
Employer resources (44)
Events (37231)
Executive appointments (495)
FDA (8905)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (974)
Gene editing (123)
Generative AI (23)
Gene therapy (372)
GLP-1 (655)
Government (1618)
Grass and pollen (5)
Guidances (369)
Healthcare (6916)
HIV (52)
Huntington's disease (28)
IgA nephropathy (63)
Immunology and inflammation (157)
Immuno-oncology (50)
Indications (112)
Infectious disease (1273)
Inflammatory bowel disease (98)
Inflation Reduction Act (6)
Influenza (99)
Intellectual property (110)
Interviews (198)
IPO (8544)
IRA (11)
Job creations (1191)
Job search strategy (775)
JPM (34)
Kidney cancer (17)
Labor market (47)
Layoffs (210)
Leadership (15)
Legal (2120)
Liver cancer (57)
Longevity (9)
Lung cancer (522)
Lymphoma (310)
Machine learning (30)
Management (11)
Manufacturing (450)
MASH (106)
Medical device (5138)
Medtech (5190)
Mergers & acquisitions (6757)
Metabolic disorders (890)
mRNA (85)
Multiple sclerosis (108)
NASH (11)
Neurodegenerative disease (234)
Neuropsychiatric disorders (74)
Neuroscience (1596)
NextGen: Class of 2026 (2073)
Non-profit (1554)
Now hiring (37)
Obesity (442)
Opinion (86)
Ovarian cancer (119)
Pain (133)
Pancreatic cancer (156)
Parkinson's disease (209)
Partnered (12)
Patents (225)
Patient recruitment (301)
Peanut (34)
People (9340)
Pharmaceutical (11)
Pharmacy benefit managers (11)
Phase 1 (8880)
Phase 2 (14174)
Phase 3 (12546)
Pipeline (5586)
Policy (73)
Postmarket research (1213)
Preclinical (3071)
Press Release (15)
Prostate cancer (200)
Psychedelics (26)
Radiopharmaceuticals (139)
Rare diseases (586)
Real estate (1356)
Recruiting (20)
Regulatory (9346)
Reports (26)
Research institute (829)
Resumes & cover letters (209)
Rett syndrome (32)
RNA editing (10)
RSV (61)
Schizophrenia (113)
Series A (148)
Series B (116)
Service/supplier (3)
Sickle cell disease (57)
Special edition (12)
Spinal muscular atrophy (96)
Sponsored (15)
Startups (1165)
State (1)
Stomach cancer (7)
Supply chain (62)
Tariffs (31)
The Weekly (24)
Vaccines (543)
Venture capital (53)
Weight loss (312)
Women's health (59)
Worklife (10)
Date
Today (110)
Last 7 days (511)
Last 30 days (1570)
Last 365 days (17930)
2026 (6185)
2025 (18207)
2024 (16897)
2023 (16186)
2022 (20645)
2021 (20271)
2020 (19028)
2019 (16794)
2018 (12749)
2017 (11970)
2016 (10565)
2015 (12717)
2014 (9228)
2013 (7262)
2012 (7941)
2011 (8061)
2010 (7267)
Location
Africa (323)
Alabama (31)
Alaska (2)
Arizona (104)
Arkansas (6)
Asia (16414)
Australia (2510)
California (7533)
Canada (2015)
China (766)
Colorado (305)
Connecticut (383)
Delaware (276)
Europe (36829)
Florida (915)
Georgia (198)
Hawaii (3)
Idaho (19)
Illinois (603)
India (44)
Indiana (324)
Iowa (12)
Japan (386)
Kansas (57)
Kentucky (20)
Louisiana (23)
Maine (50)
Maryland (777)
Massachusetts (5300)
Michigan (134)
Minnesota (327)
Mississippi (5)
Missouri (82)
Montana (9)
Nebraska (8)
Nevada (79)
New Hampshire (34)
New Jersey (2161)
New Mexico (9)
New York (1858)
North Carolina (807)
North Dakota (3)
Northern California (3791)
Ohio (173)
Oklahoma (7)
Oregon (13)
Pennsylvania (1271)
Puerto Rico (13)
Rhode Island (19)
South America (475)
South Carolina (24)
Southern California (2928)
Tennessee (98)
Texas (1194)
United States (25498)
Utah (159)
Virginia (178)
Washington D.C. (33)
Washington State (647)
West Virginia (3)
Wisconsin (112)
Wyoming (2)
255,104 Results for "5".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL
April 7, 2026
·
1 min read
Press Releases
PlaqueTec Closes $5 Million Financing
April 27, 2026
·
2 min read
IPO
The 5 largest IPOs in biopharma history
With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.
April 22, 2026
·
9 min read
·
Tristan Manalac
Press Releases
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
April 21, 2026
·
5 min read
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 5 May 2026
April 28, 2026
·
1 min read
Press Releases
Aclarion Announces $2.5 Million Stock Repurchase Plan
April 23, 2026
·
5 min read
Press Releases
Cytokinetics to Announce First Quarter Results on May 5, 2026
April 22, 2026
·
3 min read
Press Releases
GH Research Announces Pricing of $117.5 Million Underwritten Offering
April 29, 2026
·
4 min read
Press Releases
Aspire Biopharma Announces $5.0 Million Share Repurchase Program
April 27, 2026
·
8 min read
Press Releases
Alkermes to Report First Quarter Financial Results on May 5, 2026
April 22, 2026
·
1 min read
1 of 25,511
Next
